Author(s): Vermund SH, Yamamoto N, Vermund SH, Yamamoto N
Abstract Share this page
Abstract Asia has the highest numbers of tuberculosis cases (60\% of the global total) and has experienced a marked rise in HIV seroprevalence (22\% of the global total) in key subpopulations of these highly populous nations. Thus, co-infected patients are a challenge for practitioners and public health workers alike. The U.S.-Japan Cooperative Medical Science Program is spearheading interdisciplinary collaborations in Asia to address the many outstanding research priorities for HIV-tuberculosis co-infection. There is an urgency to this agenda for many reasons, including the frequency with which tuberculosis accounts for the death of HIV-infected persons in Asia, and the continued rise of multiple drug-resistant Mycobacterium tuberculosis. We review briefly the public health situation in Asia, highlighting research questions from US-Japan-Asian partner joint meetings, and cite salient studies to indicate trends and challenges.
This article was published in Tuberculosis (Edinb)
and referenced in Journal of AIDS & Clinical Research